Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The drug is given through weekly self-injections
The lack of traditional Part D controls and unclear prescriber oversight could increase risk of overprescribing and potential fraud
Additionally, Life Extension has a rocky history with the FDA, due to the company making unsupported treatment claims (among other things)
Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
_edited.jpg)
Novo Nordisk's strategy involves defending its Indian market by combining its premium brand with local distribution strength and lowering prices
US$ 24.86
US$ 29.32
US$ 26.66
